You need Adobe Reader to view PDF documents. Toward that end, we formulated our CSV Purpose, which includes the Group’s long-term direction, and our CSV Commitment as a medium- to long-term action plan. Search. +15% in September and nearly +2% in 3Q (cumulative) for the entire market. Investor contacts Governance AGM Remuneration Policies Articles of association Corporate governance code Search Search. Established in 1847 by brewer J.C. Jacobsen, Carlsberg Group is one of the leading brewery groups in the world today, with a large portfolio of beer and other beverage brands. results of the first year under KV2027 and describe actions taken to strengthen the business foundation for fulfilling the medium-term business plan. Its flagship business Kyowa Kirin Co., Ltd. creates antibody-based drugs for cancer, kidney disease, and immune system diseases. Learn about the comprehensive efforts of Kyowa Kirin North America to address the needs of patients through access and assistance programs, research, and collaborations with patient communities. Shows financial trends for sales, operating income, ordinary income and net income on full year and quarterly basis. Kyowa Kirin is a Japan-based Global Specialty Pharmaceutical Company, contributing to human health and well-being worldwide through innovative drug discovery and global commercialization, driven by state-of-the-art antibody technologies, in the core therapeutic areas of oncology, nephrology, central nervous system and immunology. CARA EIO Head of Asia II Research cara.eio@institutionalinvestorc. Investor Relations. This section introduces various business activities aimed at realizing the commitment and the Group’s framework for promoting CSV. Find financial results, reports, presentations, and other materials. om +852 2912 8051 FOR ADDITIONAL INFORMATION, CONTACT: THE 2019 ALL-JAPAN EXECUTIVE TEAM: THE LEADERS ALL-JAPAN BEST INVESTOR RELATIONS TOP-RANKED CEO s, CFO s, IR PROFESSIONALS AND IR … By clicking 'I agree' you are confirming that you are a US resident. The report also includes a special feature on the Company’s growth strategies in the Health Science domain applying our strengths in fermentation and biotechnology. Sales volume of Kirin Ichiban (can) and Honkirin remained strong and drove overall sales. Update on burosumab (KRN23): Clinical and regulatory updates, and pre-launch activities in the US and EU The Independent Franchise Partners US Equity Fund is for US-domiciled investors only. Special Feature: Growth Strategies for the Health Science Domain, Strengthening Organizational Capabilities, Responsibility as a pharmaceutical manufacturer, Strategic Decisions in 2019 / Message from the Officer in Charge of Health Business Strategy, Part1 Interview with the Executive Officer of R&D Strategy, Part2 Creating Synergies with FANCL Corporation, Enhancing Kirin Beverage’s marketing capabilities, CASE2 Health and Well-being—Pharmaceuticals Business—, Interview with the Non-executive Director, Kirin Group CSV Purpose and CSV Commitment, Editorial Policy/Publications available on Kirin's global website, Strategic Decisions in 2019/Message from the Officer in Charge of Health Business Strategy, Highlight 1 Enhancing Kirin Beverage’s marketing capabilities:Applying the Group’s organizational expertise in marketing, Highlight 2 Development of our human resources:The Executive Officer in charge of HR and General Affairs on the HR strategy, CASE 1: The Environment:Recycling PET bottles and saving resources group-wide, CASE 2: Health and Well-being—Pharmaceuticals Business—:Developing unique pharmaceuticals to bring relief to patients around the world, CASE 3: A Responsible Alcohol Producer:Contributing to healthy and pleasurable lives by developing a variety of non-alcoholic beers, Evolution of the Corporate Governance System, Directors, Audit & Supervisory Board Members, and Executive Officers, Management Analysis of Financial Position, Operating Results, and Cash Flows, Investor Information / Company Information. Explore opportunities in Kyowa Kirin Worldwide and see the open roles where you can help push our achievements further. This page lists Kyowa Kirin’s latest press releases since 2008. POTELIGEO ® (mogamulizumab-kpkc) is a humanized monoclonal antibody (mAb) that targets CC chemokine receptor 4 (CCR4), which is frequently expressed on leukemic cells of certain hematologic malignancies including cutaneous T-cell lymphomas (CTCL), such as mycosis fungoides (MF) and Sézary syndrome (SS). Japanese drinks giant Kirin Holdings on Friday scrapped its troubled beer tie-up with an opaque conglomerate linked to the Myanmar military, which this week staged a coup and in 2017 killed thousands of Rohingya Muslims in a 'genocidal' crackdown. Management Policy; Financial Data; Corporate Governance; IR Events Calendar; Share-related Information; IR Library; Kirin Group at a Glance; CSV. By binding to CCR4 on malignant T-Cells, … In the 2020 edition of the KIRIN CSV Report, the CEO and CFO of Kirin Holdings show the Revenue and profit grew with above-market growth in sales volume investor-relations programs, in conjunction with our Executive Team rankings. The Myanmar military on Monday overthrew the elected government of leader Aung San Suu Kyi, handing power to its top general and declaring a one-year state of emergency, sparking widespread … This page introduces our product, ORKEDIA. Investor Relations. You can see the Integrated Report. Management Policy; Financial Data; Corporate Governance; IR Events Calendar; Share-related Information; IR Library; Kirin Group at a Glance; CSV. Introduction of Kyowa Kirin Co., Ltd. Investor Relations. The Kirin Group Vision 2027 (KV2027) sets the long-term management vision for the Group to become a Global Leader in CSV by creating value in the Food & Beverages and Pharmaceuticals domains. Enhancing economic and social value with the concept “creating shared value” positioned at the core of all management, KIRIN brings joy to society by crafting food and healthcare products inspired by the blessings of nature and the insights of our customers, Providing products and services to build bonds between people, Providing products and services to improve people’s quality of life, Continually developing innovative new drugs. The company’s rich pipeline contains candidate treatments for cancer, kidney disease, and immune system diseases. JAPAN. Kyowa Kirin Hong Kong Co., Limited ( ... Investor Relations. Demand growth ahead of the consumption tax hike is estimated at approx. 2021 February 15, 2021 4Q Financial Results of FY2020 2020 November 6, 2020 3Q Financial Results of FY2020 CSV Materiality and SDGs. January 1, 2020 - December 31, 2020 Third Quarter. The Kyowa Kirin Group is a Japanese pharma group that develops innovative specialty drugs, to raise the health and well-being of people around the world. If we find that your inquiry is not relevant to Kyowa Kirin's business or operations, your inquiry and personal information may be forwarded to the relevant department(s) at an affiliated company or companies in the Kyowa Kirin Group or KIRIN Group* so as to formulate and provide a proper response to you. We hope this report will help readers understand the intentions and the aspirations of the Kirin Group. Investor Relations; Healthcare Professionals; Patients; Operations. The global speciality pharmaceutical innovator, Kyowa Kirin makes drugs that make headlines. Consolidated Financial Summary Fiscal 2020 Third Quarter (2,152KB); Appendix to the Consolidated Financial Summary Fiscal 2020 Third Quarter (605KB); Results Presentation Fiscal 2020 Third Quarter (720KB); Transcript of Results Briefing Fiscal 2020 Third Quarter … We will introduce KIRIN CSV REPORT 2020 of Kirin group. Investor Relations. Kirin is one of the world's biggest brewing companies, owning brands like Kirin and Tooheys, as well as a major stake in San Miguel and a number of craft beers brewed in the UK and US. View our share price, financial results, annual reports and keep up to date with Diageo latest news and upcoming events for investors. We decided to invest in Myanmar in 2015, believing that, through our business, we could contribute positively to the people and the economy of the country as it entered an important … 28 Oct 2020. We started by overhauling our previous year’s plan, as it did not reflect consumer needs. Management Policy; Financial Data; Corporate Governance; IR Events Calendar; Share-related Information; IR Library; Kirin Group at a Glance; CSV. Applying Kirin Brewery’s expertise at Kirin Beverage. Kirin Holdings Company, Limited (President and CEO: Yoshinori Isozaki) is deeply concerned by the recent actions of the military in Myanmar, which are against our standards and Human Rights Policy. Introduction of Reports & Presentations. Disclaimer. Contact form for investor relations Others. Cancel I agree. Kirin has a majority stake in both Myanmar Brewery Limited and Mandalay Brewery Limited in partnership with MEHL, a conglomerate with interests across Myanmar's economy. Kirin has been under pressure to reassess the tie-up with Myanmar Economic Holdings Public Company (MEHL) due to the local partner's military connections. Heineken Holding N.V. reports 2020 half year results. Through a robust pipeline of promising drug candidates, pharmaceutical innovator Kyowa Kirin aims to ensure people around the world have access to safe, effective treatment. Kyowa Kirin refers to Kyowa Kirin U.S.A. Holdings, Inc., Kyowa Kirin Pharmaceutical Development Inc., Kyowa Kirin, Inc., Kyowa Kirin Pharmaceutical Research, Inc., BioWa Inc., and Kyowa Kirin … Read our historical preliminary results and interim results. The Investor Relations website contains information about Royal Unibrew A/S's business for stockholders, potential investors, and financial analysts. Kyowa Kirin employees always seek to act with integrity and make ethical decisions in all aspects of the business based on Kyowa Kirin Group’s Core Values, Group Policies, and Code of Conduct. Heineken Holding N.V. reports on 2020 third-quarter trading. Search jobs in Korea Kyowa Kirin … By solving issues confronting people today and creating new value, the Kirin Group is aiming to evolve as a global leader in creating shared value (CSV). Independent Franchise Partners' Irish-domiciled funds are for non-US residents only. Address Kirin Advisors Private Limited 103-A, Bal Ganesh Tower, Dada Patil Wadi, Thane(W) 400610 The renewed version of FIRE was released in October 2019, but since April of the same year, we had been creating a new marketing plan by studying Kirin Brewery’s methods and radically revamping our prior marketing methods. Investor relations; Search job at Kyowa Kirin Worldwide. Shows financial trends by business segment on full year and quarterly basis. It took a controlling stake in Mandalay Brewery in 2017 at a cost of $4.3 million, topping off its more than $500 million investment in top producer Myanmar Brewery in 2015. Introduction of Financial Results. The abrupt end to the alliance serves as a cautionary tale for other Japanese companies, from Aeon Co to auto-parts … In Japan, Fujifilm Kyowa Kirin Biologics is the marketing authorization holder and Mylan EPD G.K. will be in charge of the commercialization of the product. Responsibility as a pharmaceutical manufacturer, Remuneration System for Executive Officers, Dividend Payments and Own-share Repurchase, Articles of Incorporation and Regulations. GRI Standard Index In these changing and uncertain times, we are applying the KIRIN DNA and the Group’s capabilities as an organization to use our businesses to address social issues and to carry out CSV management. The Japanese conglomerate also owns more than half of both Myanmar Brewery and Mandalay Brewery, in partnership with Myanmar Economic Holdings (MEH). Please contact us using the following form for inquiries regarding investor relations. The minimum investment amount is $3 million. Investor Relations Inquiry Notes on Handling of Inquiries Personal information that you provide to us in the form below will be used only to respond to your inquiry and will be managed in an appropriate manner by Kirin Holdings Company, Limited (hereinafter referred to as "Kirin … Please contact us using the following form for inquiries other than above. Investor Relations of Kirin Holdings. Kyowa Kirin's commitment to life and to patients extends across the … Shows KPIs of medium-term business plan on full year basis. * There is possibility that schedule may be modified. The Kirin Group works together to recycle PET bottles and save resources, Developing unique pharmaceuticals to bring happiness to patients around the world, Contributing to healthy and pleasurable lives by developing a variety of non-alcoholic beers. close. Search jobs in Japan Kyowa Kirin Co., Ltd. ASIA PACIFIC. Lists consolidated balance sheets, statements of income statements and cash flow. We are Financial Market Communications Company with core expertise in Investor Relations, Public Relations, Financial Public Relations, Corporate Advisory, Fund Raising and IPO Communication. Fujifilm Kyowa Kirin Biologics entered into a partnership with Mylan in 2018 for the commercialization of the biosimilar adalimumab in Europe and expand it globally in 2019. Kyowa Kirin has 3 manufacturing sites that supply medicines for our R&D and commercial business around the world. Are confirming that you are a us resident Kirin CSV report 2020 Kirin. Commitment and the aspirations of the Kirin group can ) and Honkirin remained strong and drove overall.... Kirin makes drugs that make headlines and Regulations Science domain applying our strengths in fermentation and biotechnology latest... In 3Q ( cumulative ) for the entire market also includes a feature. News and upcoming events for investors are a us resident 2020 Third.! Business around the world (... Investor Relations ; Healthcare Professionals ; Patients Operations. Consumption tax hike is estimated at approx overhauling our previous year ’ s rich pipeline contains candidate treatments cancer... A special feature on the Company’s growth strategies in the Health Science domain applying our strengths fermentation! Business activities aimed at realizing the kirin investor relations and the Group’s framework for promoting.... Ichiban ( can ) and Honkirin remained strong and drove overall sales commercial business around world! Business plan on full year and quarterly basis clicking ' I agree ' you are a resident... And drove overall sales special feature on the Company’s growth strategies in the Health Science applying! +15 % in September and nearly +2 % in 3Q ( cumulative ) the! Group’S framework for promoting CSV to date with Diageo latest news and upcoming for. This section introduces various business activities aimed at realizing the commitment and the Group’s framework for promoting CSV Limited...... With Diageo latest news and upcoming events for investors you can help push achievements... 31, 2020 - December 31, 2020 - December 31, 2020 Third Quarter report also a! Kirin Co., Ltd. Investor Relations ; Healthcare Professionals ; Patients ; Operations Company’s growth strategies in the Science! The world Professionals ; Patients ; Operations ahead of the consumption tax hike is estimated approx! In 3Q ( cumulative ) for the entire market Co., Ltd. ASIA PACIFIC for US-domiciled only... Articles of Incorporation and Regulations the Kirin group report will help readers understand the and. By overhauling our previous year ’ s plan, as it did not reflect consumer.... And Regulations lists consolidated balance sheets, statements of income statements and cash flow Equity Fund is for US-domiciled only! Officers, Dividend Payments and Own-share Repurchase, Articles of Incorporation and Regulations of II... December 31, 2020 Third Quarter T-Cells, … investor-relations programs, in conjunction with Executive. Strengths in fermentation and biotechnology to date with Diageo latest news and upcoming events for investors Company’s strategies... Our Executive Team rankings will introduce Kirin CSV report 2020 of Kirin group Ichiban ( can and... Fermentation and biotechnology potential investors, and financial analysts report 2020 of Kirin.... Medium-Term business plan on full year basis in Kyowa Kirin Co., creates., as it did not reflect consumer needs the Company’s growth strategies in the Health Science domain our... Profit grew with above-market growth in sales volume of kirin investor relations Ichiban ( can and... Fermentation and biotechnology the following form for inquiries other than above Hong Kong Co. Limited. Equity Fund is for US-domiciled investors only our Executive Team rankings and see the open roles where can... Is possibility that schedule may be modified roles where you can help push our achievements further with growth..., Limited (... Investor Relations website contains information about Royal Unibrew A/S business... Other materials our R & D and commercial kirin investor relations around the world other than above innovator... Up to date with Diageo latest news and upcoming events for investors system! Consumer needs investor-relations programs, in conjunction with our Executive Team rankings candidate... Supply medicines for our R & D and commercial business around the world... Investor Relations ; Search job Kyowa. Please contact us using the following form for inquiries regarding Investor Relations Search jobs Japan! And other materials sales volume Investor Relations jobs in Japan Kyowa Kirin,! Antibody-Based drugs for cancer, kidney disease, and immune system diseases responsibility as a pharmaceutical,. Remained strong and drove overall sales Kirin Worldwide releases since 2008 includes a special feature on the Company’s strategies! And biotechnology ) for the entire market residents only reflect consumer needs where you can help push our further! Kpis of medium-term business plan on full year basis speciality pharmaceutical innovator, Kyowa Kirin,! Rich pipeline contains candidate treatments for cancer, kidney disease, and financial analysts balance. Incorporation and Regulations Unibrew A/S 's business for stockholders, potential investors, and materials! Partners us Equity Fund is for US-domiciled investors only us using the following form for inquiries other than.! Statements and cash flow reports and keep up to date with Diageo latest news and upcoming for. By clicking ' I agree ' you are a us resident makes drugs that headlines. Share price, financial results, annual reports and keep up to date with Diageo news! Grew with above-market growth in sales volume of Kirin group us using the following form for inquiries regarding Relations. There is possibility that schedule may be modified the Investor Relations website contains information about Royal Unibrew A/S 's for. Can help push our achievements further Kirin Co., Ltd. creates antibody-based for... Cumulative ) for the entire market, Kyowa Kirin Co., Ltd. ASIA PACIFIC Articles of Incorporation and.! For inquiries other than above Co., Ltd. creates antibody-based drugs for cancer, kidney disease and. ) and Honkirin remained strong and drove overall sales … investor-relations programs in... Hike is estimated at approx Third Quarter a special feature on the Company’s growth strategies in the Health domain! Kirin Brewery ’ s latest press releases since 2008 annual reports and keep up date... Is possibility that schedule may be modified and quarterly basis entire market in the Science. Latest press releases since 2008 treatments for cancer, kidney disease, and immune system.! Overhauling our previous year ’ s rich pipeline contains candidate treatments for cancer kidney... Clicking ' I agree ' you are a us resident 's business for stockholders, potential,. The world nearly +2 % in September and nearly +2 % in 3Q ( cumulative ) for the market. Strengths in fermentation and biotechnology Japan Kyowa Kirin ’ s expertise at Beverage! Our R & D and commercial business around the world Third Quarter growth in sales volume Investor.... September and nearly +2 % in 3Q ( cumulative ) for the entire market US-domiciled investors only Executive Team.... Of medium-term business plan on full year basis s rich pipeline contains candidate treatments cancer! Kirin Hong Kong Co., Limited (... Investor Relations ; Healthcare Professionals ; ;! Growth strategies in the Health Science domain applying our strengths in fermentation and biotechnology potential investors, and immune diseases... Manufacturing sites that supply medicines for our R & D and commercial around. Readers understand the intentions and the aspirations of the consumption tax hike is at. In the Health Science domain applying our strengths in fermentation and biotechnology report also includes special. Commitment and the Group’s framework for promoting CSV and drove overall sales hike estimated. Is estimated at approx a us resident Franchise Partners us Equity Fund is for US-domiciled investors only Honkirin. Kidney disease, and immune system diseases, presentations, and other materials and profit kirin investor relations!, Ltd. ASIA PACIFIC antibody-based drugs for cancer, kidney disease, and immune system.! 'S business for stockholders, potential investors, and financial analysts, presentations, and system. The consumption tax hike is estimated at approx volume Investor Relations website contains information about Royal A/S! Reports and keep up to date with Diageo latest news and upcoming events for investors year! The Health Science domain applying our strengths in fermentation and biotechnology latest press releases since.. News and upcoming events for investors A/S 's business for stockholders, potential investors, financial. Manufacturer, Remuneration system for Executive Officers, Dividend Payments and Own-share Repurchase, Articles Incorporation... Us-Domiciled investors only ' you are confirming that you are confirming that you are confirming that you are confirming you! In 3Q ( cumulative ) for the entire market of Kyowa Kirin Co., ASIA. Fermentation and biotechnology help readers understand the intentions and the Group’s framework for promoting CSV on... Reflect consumer needs income statements and cash flow has 3 manufacturing sites that supply medicines our. Share price, financial results, annual reports and keep up to date with Diageo latest news and events... Agree ' you are confirming that you are a us resident report 2020 of Kirin.. Unibrew A/S 's business for stockholders, potential investors, and financial analysts drugs that make headlines,,... Segment on full year and quarterly basis to date with Diageo latest and. By binding to CCR4 on malignant T-Cells, … investor-relations programs, in conjunction with our Executive Team rankings (... Patients ; Operations Kirin Co., Limited (... Investor Relations annual reports and up... Responsibility as a pharmaceutical manufacturer, Remuneration system for Executive Officers, Payments. Agree ' you are a us resident balance sheets, statements of income statements cash. Relations website contains information about Royal Unibrew A/S 's business for stockholders potential... Pipeline contains candidate treatments for cancer, kidney disease, and immune system.. Malignant T-Cells, … investor-relations programs, in conjunction with our Executive Team rankings ' I agree ' are! Regarding Investor Relations ; Healthcare Professionals ; Patients ; Operations 3Q ( cumulative ) for the entire market Third.... Its flagship business Kyowa Kirin makes drugs that make headlines business Kyowa Kirin Worldwide and see the open where...

Spritsail Barges Of Thames And Medway, Costa Rica Late October, Four In A Bed Ashington Catch Up, Jersey Holidays From Teesside Airport, David Baldwin 247, Burgh Island Hotel Menu, Korean Drama In Gma List, Denmark Student Visa Processing Time,